Inhibitors of recurrence of hematopoietic malignancies in patients receiving hematopoietic stem cell transplantation

摘要

2-amino-2-[4-(3-benzyloxyphenylthio)-2-chlorophenyl]ethyl-propane-1,3-diol or a pharmaceutically acceptable salt thereof, as an active ingredient, of hematologic malignancies A drug that suppresses recurrence of hematologic malignancies and/or improves survival rate in a patient who has undergone hematopoietic stem cell transplantation for treatment.